Cannabinoid suppression of Noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat

Journal of Neurophysiology

Volumn 81, Issue 2, 1999, Pages 575-583

  Hohmann, Andrea G ^a,b   Tsou, Kang ^a   Walker, J Michael ^a  

^a BROWN UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID;

ANIMAL EXPERIMENT; ARTICLE; INFORMATION PROCESSING; LUMBAR SPINE; MALE; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SPINAL CORD DORSAL HORN;

EID: 0033064793     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.1999.81.2.575     Document Type: Article

References (67)

1. ABOOD, M. E. AND MARTIN, B. R. Neurobiology of marijuana abuse. Trends Pharmacol. Sci. 13: 201-206, 1992.
2. BELTRAMO, M., STELLA, N., CALIGNANO, A., LIN, S. Y., MAKRIYANNIS, A., AND PIOMELLI, D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277: 1094-1097, 1997.
3. BICHER, H. I. AND MECHOULAM, R. Pharmacological effects of two active constituents of marihuana. Arch. Int. Pharmacodyn. 172: 24-30, 1968.
4. BLOOM, A. S., DEWEY, W. L., HARRIS, L. S., AND BROSIUS, K. K. 9-nor-9b-Hydroxyhexahydrocanninol, a cannabinoid with potent antinociceptive activity: comparisons with morphine. J. Pharmacol. Exp. Ther. 200: 263-270, 1977.
5. 9-tetrahydrocannabinol in the rat and mouse. Pshychopharmacology 25: 275-280, 1972.
6. CALIGNANO, A., LA RANA, G., GIUFFRIDA, A., AND PIOMELLI, D. Control of pain initiation by endogenous cannabinoids. Nature 394: 277-281, 1998.
7. CARTMELL, S. M. GELGOR, L., AND MITCHELL, D. A revised rotarod procedure for measuring the effect of antinociceptive drugs on motor function in the rat. J. Pharmacol. Methods 26: 149-159, 1991.
8. CALVILLO, U., HENRY, J. L., AND NEUMAN, R. S. Effects of morphine and naloxonc on dorsal horn neurons in the cat. Can. J. Physiol. Pharmacol. 52: 1207-1211, 1974.
9. COGHILL, R. C., MAYER, D. J., AND PRICE, D. D. Wide dynamic range but not nociceptive-specific neurons encode mutlidimensional features of prolonged repetitive heat pain J. Neurophysiol. 69: 703-716, 1993.
10. 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 263: 1118-1120, 1992.
11. D'AMBRA, T. E., ESTEP, K. G., BELL, M. R., EISSENSTAT, M. A., JOSEF, K. A., WARD, S. J., HAYCOCK, D. A., BAIZMAN, E. R., CASIANO, F. M., BEGLIN, N. C., CHIPPARI, S. M., GREGO, J. D., KULLNIG, R. K., AND DALEY, G. T. Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor. J. Med. Chem. 35: 124-135, 1992.
12. D'AMOUR, F. E. AND SMITH, D. L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72: 74-79, 1941.
13. DEVANE, W. A., HANUS, L., BREUER, A., PERTWEE, R. G., STEVENSON, L. S., GRIFFIN, G., GIBSON, D., MANDELBAUM, A., ETINGER, A., AND MECHOULAM, R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949, 1992.
14. DI MARZO, V., FONTANA, A., CADAS, H., SCHINELLI, S., CIMINO, G., SCHWARTZ, J.-C., AND PIOMELLI, D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372: 686-691, 1994.
15. DOUGLASS, D. K. AND CARSTENS, E. Response of rat sacral spinal neurons to mechanical and noxious thermal stimulation of the tail. J. Neurophysiol. 77: 611-620, 1997.
16. EINSPAHR, F. J. AND PIERCEY, M. F. Morphine depresses dorsal horn neuron responses to controlled noxious and non-noxious cutaneous stimulation. J. Pharmacol. Exp. Ther. 213: 456-461, 1980.
17. 2 receptors. Mol. Pharmacol. 48: 443-450, 1995.
18. FELDER, C. C. VELUZ, J. S., WILLIAMS, H. L., BRILEY, E. M., AND MATSUDA, L. A. Cannabinoid agonists stimulate both receptor and nonreceptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol. Pharmacol. 42: 838-845, 1992.
19. FRIDE, E. AND MECHOULAM, R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231: 313-314, 1993.
20. GIESLER, O. J., JR., MENETREY, D., GUILBAUD, G., AND BESSON, J.-M. Lumbar cord neurons at the origin of the spinothalamic tract in the rat. Brain Res. 118: 320-324, 1976.
21. 9-Tetrahydrocannabinol and the extrapyramidal system. Psychopharmacology 54: 87-99, 1977.
22. GREENE, E. C. Anatomy of the Rat. New York: Hafner, 1935.
23. GREENHOUSE, S. W. AND GEISSER, S. On methods in the analysis of profile data. Psychometrika 24: 95-112, 1959.
24. HERKENHAM, M., LYNN, A. B., JOHNSON, M. R., MELVIN, L. S., DE COSTA, B. R., AND RICE, K. C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11: 563-583, 1991.
25. HOHMANN, A. G. AND HERKENHAM, M. Regulation of cannabinoid and mu opioid receptor binding sites following neonatal capsaicin treatment. Neurisci. Lett. 252: 13-16, 1998.
26. HOHMANN, A. G. AND HERKENHAM, M. Localization of central cannabinoid CBl receptor mRNA in neuronal subpopulations of rat dorsal root ganglia: a double label in situ hybridization study. Neurosience. In press. 1999.
27. HOHMANN, A. G., MARTIN, W. J., TSOU, K., AND WALKER, J. M. Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN55,212-2. Life Sci. 56: 2111-2119, 1995.
28. HOMMA, E., COLLINS, J. G., KITAHATA, L. M., MATSUMOTO, M., AND KAWAHAR, M, Suppression of noxiously evoked WDR dorsal horn neuronal activity by spinally administered morphine Anesthesiology 58: 232-236, 1983.
29. JACOB, J., RAMABADRAN, K., AND CAMPOS-MEDEIROS, M. A pharmacological analysis of levonantradol antinociception in mice. J. Clin. Pharmacol. 21: 327S-333S. 1981.
30. KUSTER, J. E., STEVENSON, J. I., WARD, S. J., D'AMBRA, T. E., AND HAYCOCK, D. A. Aminoalkylindole binding in rat cerebellum: Selective displacement by natural and synthetic cannabonoids. J. Pharmacol. Exp. Ther. 264: 1352-1363, 1993.
31. LAKE, K. D., MARTIN, B. R., KUNOS, G., AND VARGA, K. Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension 29: 1204-1210, 1997.
32. LICHTMAN, A. H., COOKE, S. A., AND MARTIN, B. R. Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement. J. Pharmacol. Exp. Ther. 276: 585-593, 1996.
33. LICHTMAN, A. H. AND MARTIN, B. R. Spinal and supraspinal components of cannabinoid-induced antinociception. J. Pharmacol. Exp. Ther. 258: 517-523, 1991a.
34. 2-noradrenergic mechanism. Brain Res. 559: 309-314, 1991b.
35. LOEWE, S. Studies on the pharmacology and acute toxicity of compounds with marihuana activity. J. Pharmacol. Exp. Ther. 88: 154-161, 1946.
36. MACKIE, K., DEVANE, W., AND HILLE, B. Anandamide, an endogenous cannabinoid inhibits calcium currents as a partial agonist in N18 neuroblastoma cells Mol. Pharmacol. 44: 498-503, 1993.
37. MAIXNER, W., DUBNER, R., BUSHNELL, M. C., KENSHALO JR., D. R., AND OLIVERAS, J.-L. Wide dynamic range neurons participate in the encoding process by which monkeys perceive the intensity of noxious heat stimuli. Brain Res. 374: 385-388, 1986.
38. MARTIN, B. R., COMPTON, D. R., THOMAS, B. F., PRESCOTT, W. R., LITTLE, P. J., RAZDAN, R. K., JOHNSON, M. R., MELVIN, L. S., MECHOULAM, R., AND WARD, S. J. Behavioral, biochemical and molecular modeling evaluation of cannabinoid analogs. Pharmacol. Biochem. Behav. 40: 471-478, 1991.
39. MARTIN, W. J., HOHMANN, A. G., AND WALKER, J. M. Inhibition of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by the cannabinoid WIN55,212-2: correlation of clectrophysiological effects with antinociceptive actions. J. Neurosci. 16: 6601-6611, 1996.
40. MARTIN, W. J., LAI, N. K., PATRICK, S. L., TSOU, K., AND WALKER, J. M. Antinociceptive actions of cannabinoids following intraventricular administration in rats. Brain Res. 629: 300-304, 1993.
41. MARTIN, W. J., PATRICK, S. L., COFFIN, P. O., TSOU, K., AND WALKER, J. M. An examination of the central sites of action of cannabinoid-induced antinociception in the rat. Life Sci. 56: 2103-2110, 1995.
42. MARTIN, W. J. TSOU, K., AND WALKER, J. M. Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla. Neurosci. Lett. 242: 33-36, 1998.
43. MATSUDA, L. A., LOLAIT, S. J., BROWNSTEIN, M. J., YOUNG, A. C., AND BONNER, T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-563, 1990.
44. MECHOULAM, R., BEN-SHABAT, S., HANUS, L., LIGUMSKY, M., KAMINSKI, N. E., SCHATZ, A. R., GOPHER, A., ALMOG, S., MARTIN, B. R., COMPTON, D. R., PERTWEE R., GRIFFIN, G., BAYEWITCH, M., BARG, J., AND VOGEL, Z. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50: 83-90, 1995.
45. MENDELL, L. M. Physiological properties of unmyelinated fiber projection to the spinal cord. Exp. Neurol. 16: 316-332, 1966.
46. MENG, I. D., MANNING, B. H., MARTIN, W. J., AND FIELDS, H. L. An analgesia circuit activated by cannabinoids Nature 395: 381-383, 1998.
47. 9'-tetrahydrocannabinol as measured with the formalin test. Eur. J. Pharmacol. 61: 313-315, 1980.
48. MUNRO, S., THOMAS, K. L., AND ABU-SHAAR, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65, 1993.
49. PAXINOS, G. AND WATSON, C. The Rat Brain in Stereotaxic Coordinates (2nd ed.). New York: Academic, 1986.
50. PRICE, D. D. AND DUBNER, R. Neurons that subserve the sensory discriminative aspects of pain. Pain 3: 307-338, 1977.
51. RICHARDSON, J. D., AANONSEN, L., AND HARGREAVES, K. M. Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia. J. Neurosci. 18: 451-457, 1998a.
52. RICHARDSON, J. D., AANONSEN, L., AND HARGREAVES, K. M. Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CBI receptors. Pain 75: 111-119, 1998b.
53. RICHARDSON, J. D., AANONSEN, L., AND HARGREAVES, K. M. Antihyperalgesic effects of spinal cannabinoids. Eur. J. Pharmacol. 345: 145-153, 1998c.
54. RINALDI-CARMONA, M., BARTH, F., HAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NELIAT, G., CAPUT, D., FERRARA, P., SOUBRIE, P., BRELIERE, J. C., AND LE FUR, G. SR141716A, a potent and selective antagonist of the brain cannahinoid receptor. FEBS Lett. 350: 240-244, 1994.
55. SCREMIN, O. U. Cerebral vascular system. In: The Rat Nervous System (2nd ed.), edited by G. Paxinos. Sydney. Australia: Academic, 1995, p. 28-29.
56. 9-tetrahydrocannabinol (THC). J. Pharmacol. Exp. Ther. 186: 646-655, 1973.
57. STRANGMAN, N. M., PATRICK, S. L., HOHMANN, A. G., TSOU, K., AND WALKER, J. M. Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity. Brain Res. 813: 323-328, 1998.
58. THURSTON, C. L. AND RANDICH, A. Responses of ON and OFF cells in the rostral ventral medulla to stimulation of vagal afferents and changes in mean arterial blood pressure in intact and cardiopulmonary deafferented rats. Pain 62: 19-38, 1995.
59. TSOU K., BROWN, S., SAÑUDO-PEÑA, M. C., MACKIE, K., AND WALKER, J. M. Immunohistochemical distribution of cannabinoid CBl receptors in the rat central nervous system. Neuoscience 83: 393-411, 1998.
60. TSOU, K., LOWITZ, K. A., HOHMANN, A. G., MARTIN, W. J., HATHAWAY, C. B., BEREITER, D. A., AND WALKER, J. M. Suppression of noxious stimulus-evoked expression of fos-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist. Neuroscience 70: 791-798, 1996.
61. 9-tetrahydrocannabinol and its pharmacological characteristics. Trends Pharmacol. Sci. 1: 126-129, 1980.
62. VARGA, K., LAKE, K. D., HUANGFU, D., GUYENET, P. G., AND KUNOS G. Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension 28: 682-686, 1996.
63. VARGA, K., LAKE, K. D., MARTIN, B. R., AND KUNOS, G. Novel antagonist implicates the CBl cannabinoid receptor in the hypotensive action of anandamide. Eur. J. Pharmacol. 278: 279-283, 1995.
64. VOGEL, Z., BARG, J., LEVY, R., SAYA, D., HELDMAN, E., AND MECHOULAM, R. Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase J. Neurochem. 61: 352-355, 1993.
65. 9-trans-tetrahydrocannabinol. J. Pharm. Pharmacol. 26: 186-192, 1974.
66. WILCOX, G. L. AND GIESLER, JR., G. J. An instrument using a multiple layer peltier device to change skin temperature rapidly. Brain Res. Bull. 12: 143-146, 1984.
67. YAKSH, T. L. The antinociceptive effects of intrathecally administered levonantradol and desacetyllevonantradol in the rat. J. Clin. Pharmacol. 21: 334S-340S, 1981.